MENU
Showcases Stock ranks Forex

Edwards Lifesciences Corp (EW)
105.46  -0.66 (-0.62%) 08-08 16:00
Open: 106.81 Pre. Close: 106.12
High: 107.18 Low: 104.9
Volume: 1,663,303 Market Cap: 65,379M
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides the PASCAL and Cardioband transcatheter valve repair systems for minimally-invasive therapy. In addition, it offers surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; KONECT RESILIA, a pre-assembled aortic tissue valved conduit for patients who require replacement of the valve, root, and ascending aorta; and HARPOON Beating Heart Mitral Valve Repair System for patients with degenerative mitral regurgitation. Further, the company provides critical care solutions, including advanced hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Prices Prediction (Update @5:00pm)
If tomorrow: Open lower Open higher
High: 107.266 - 107.808 107.808 - 108.155
Low: 103.602 - 104.324 104.324 - 104.785
Close: 104.426 - 105.514 105.514 - 106.209
Stock Technical Analysis
Overall:     
Target: Six months: 126.05
One year: 147.23
Support: Support1: 99.19
Support2: 93.80
Resistance: Resistance1: 107.92
Resistance2: 126.05
Pivot: 103.22
Moving Averages: MA(5): 104.42
MA(20): 101.72
MA(100): 103.46
MA(250): 110.63
MACD: MACD(12,26): 2.03
Signal(12,26,9): 1.83
%K %D: %K(14,3): 76.35
%D(3): 72.32
RSI: RSI(14): 59.87
52-Week: High: 131.73
Low: 85.58
Change(%): -7.8
Average Vol(K): 3-Month: 2592
10-Days: 2766
Price, MAs and Bollinger Bands
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.

[ EW ] has closed below upper band by 24.2%. Bollinger Bands are 45.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 0 bars. This is a sign that the market may be about to initiate a new trend.
Stock chart
Stock News
Mon, 08 Aug 2022
Stryker Corp. stock outperforms competitors on strong trading day - MarketWatch

Mon, 08 Aug 2022
Boston Scientific Corp. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch

Fri, 05 Aug 2022
Have Edwards Lifesciences Corporation (NYSE:EW) Insiders Been Selling Their Stock? - Simply Wall St

Wed, 03 Aug 2022
Edwards Lifesciences Co. (NYSE:EW) Shares Acquired by Victory Capital Management Inc. - Defense World

Fri, 29 Jul 2022
EDWARDS LIFESCIENCES CORP Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q) - Marketscreener.com

Thu, 28 Jul 2022
Edwards Lifesciences Corporation (EW) CEO Mike Mussallem on Q2 2022 Results - Earnings Call Transcript - Seeking Alpha

Financial Analysis
Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Outperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Exchange:  New York Stock Exchange
Sector:  Healthcare
Industry:  Medical Devices
Shares Out. (M) 619.94
Shares Float (M) 614.33
% Held by Insiders 0.80
% Held by Institutions 85.00
Shares Short (K) 6660
Shares Short Prior Month (K) 5870
Stock Financials
EPS 2.280
Book Value (p.s.) 9.590
Profit Margin 27.18
Operating Margin 30.75
Return on Assets (ttm) 12.8
Return on Equity (ttm) 26.3
Qtrly Rev. Growth -0.2
Gross Profit (p.s.) 6.420
Sales Per Share 8.630
EBITDA (p.s.) 2.871
Qtrly Earnings Growth -16.70
Operating Cash Flow (M) 1530.00
Levered Free Cash Flow (M) 1100.00
Stock Valuation
PE Ratio 46.25
PEG Ratio 3.02
Price to Book value 11.00
Price to Sales 12.22
Price to Cash Flow 42.73
Stock Dividends
Dividend
Dividend Yield
Dividend Growth

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android